A Study of the Safety and Efficacy of Fabrazyme (Agalsidase Beta) as Compared to Placebo in Patients With Advanced Fabry Disease
Clinical trial NCT00074984 · COMPLETED
Trial details
- NCT number
- NCT00074984
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2001-02-01
- Primary completion
- 2004-01-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.